Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia
Clinical trial NCT00006045 · UNKNOWN
Trial details
- NCT number
- NCT00006045
- Sponsor
- Facet Biotech
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-03-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.